Stock A017180 MYUNGMOON PHARM CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

Company MYUNGMOON Pharm co.,Ltd

Equities

A017180

KR7017180001

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-14 pm EDT 		5-day change 1st Jan Change
2,070 KRW -2.13% Intraday chart for MYUNGMOON Pharm co.,Ltd -4.17% -9.41%
Mar. 20 MYUNGMOON Pharm co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Tranche Update on MYUNGMOON Pharm co.,Ltd's Equity Buyback Plan announced on May 25, 2023. CI

Business Summary

MyungMoon Pharm. Co., Ltd. is a Korea-based company mainly engaged in the manufacture of pharmaceuticals. Its products include ethical (ETC) drugs and over the counter (OTC) drugs. Its ETC drugs include anesthetic agents, digestive system drugs, rheumatoid arthritis remedies, central nervous system drugs, circulatory drugs, anti-depressant agents, anti-diabetic agents, antibiotics, hormone agents, narcotics and drugs for dermatology systems. Its OTC drugs include antinauseant agents, hepatic agents, immunologic agents, antidiarrheal agents, skin external preparations, antiallergic agents, muscle relaxants, cold drugs and parasiticides. The Company is also involved in the operation golf courses. January 2, 2012, the Company completed the merger with its wholly owned subsidiary.

Number of employees: 283

Sales per Business

KRW in Million2022Weight2023Weight Delta
Pharmaceuticals
95.1 %
143,571 94.4 % 161,194 95.1 % +12.27%
Service
4.9 %
8,564 5.6 % 8,374 4.9 % -2.22%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
97.8 %
148,443 97.6 % 165,876 97.8 % +11.74%
Overseas
2.2 %
3,691 2.4 % 3,691 2.2 % 0.00%

Managers

Managers TitleAgeSince
Choon-Sik Park CEO
 Chief Executive Officer 61 -
Seok-Min Woo CHM
 Chairman 56 01-01-31
Jang-Ho Lee CTO
 Chief Tech/Sci/R&D Officer 51 -
Cheol-Han Bae BRD
 Director/Board Member 72 -
Hyeong-Guk Lee SAM
 Sales & Marketing 59 -
Hang-Jun Jo AUD
 Comptroller/Controller/Auditor 54 17-09-10
Heung-Mook Choi PRN
 Corporate Officer/Principal 62 -
Man-Jeong Heo PRN
 Corporate Officer/Principal 57 -
Yoon-Soo Jang PRN
 Corporate Officer/Principal 60 -
Young-Mi Lee PRN
 Corporate Officer/Principal 61 -

Members of the board

Members of the board TitleAgeSince
Seok-Min Woo CHM
 Chairman 56 01-01-31
Yong-Jin Jeong BRD
 Director/Board Member 59 -
Cheol-Han Bae BRD
 Director/Board Member 72 -
Choon-Sik Park CEO
 Chief Executive Officer 61 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 33,953,454 26,384,957 ( 77.71 %) 426,256 ( 1.255 %) 77.71 %

Shareholders

NameEquities%Valuation
Seok-Min Woo
18.72 %
6,356,146 18.72 % 11 M ₩
KYONGBO PHARMACEUTICAL CO., LTD
4.211 %
1,429,642 4.211 % 2 M ₩
MYUNGMOON PHARM CO.,LTD
1.240 %
421,172 1.240 % 717 989 ₩
Jung-bin Woo
1.097 %
372,393 1.097 % 634 833 ₩
Cheol-Han Bae
0.8274 %
280,928 0.8274 % 478 909 ₩
Su-yeon Lee
0.4022 %
136,544 0.4022 % 232 772 ₩
Young-Mi Lee
0.2369 %
80,430 0.2369 % 137 112 ₩
Yoon-Soo Jang
0.2249 %
76,353 0.2249 % 130 162 ₩
Joon-il Jung
0.1178 %
40,000 0.1178 % 68 190 ₩
Mirae Asset Global Investments Co., Ltd.
0.004951 %
1,681 0.004951 % 2 866 ₩

Holdings

NameEquities%Valuation
MYUNGMOON PHARM CO.,LTD
1.24%
 421,172 1.24% 717,989 $

Company contact information

MYUNGMOON Pharm Co., Ltd.

26 Jeyakgongdan 2-gil Hyangnam-eup

18622, Hwaseong-si

+

http://www.mmpharm.co.kr
address MYUNGMOON Pharm co.,Ltd(A017180)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
MYUNGMOON PHARM CO.,LTD Stock MYUNGMOON Pharm co.,Ltd
-9.41% 50.03M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+28.79% 676B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+23.78% 559B
JOHNSON & JOHNSON Stock Johnson & Johnson
-5.84% 356B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.75% 320B
ABBVIE INC. Stock AbbVie Inc.
+4.32% 286B
ASTRAZENECA PLC Stock AstraZeneca PLC
+3.17% 213B
NOVARTIS AG Stock Novartis AG
+0.45% 207B
ROCHE HOLDING AG Stock Roche Holding AG
-8.83% 199B
PFIZER, INC. Stock Pfizer, Inc.
-10.00% 147B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A017180 Stock
  4. Company MYUNGMOON Pharm co.,Ltd